Literature DB >> 30763236

Canadian Urological Association guideline: Muscle-invasive bladder cancer.

Girish S Kulkarni1, Peter C Black2, Srikala S Sridhar3, Anil Kapoor4, Alexandre R Zlotta1, Bobby Shayegan4, Ricardo A Rendon5, Peter Chung6, Theodorus van der Kwast7, Nimira Alimohamed8, Yves Fradet9, Wassim Kassouf10.   

Abstract

Entities:  

Year:  2019        PMID： 30763236      PMCID： PMC6737737          DOI： 10.5489/cuaj.5902

Source DB:  PubMed          Journal:  Can Urol Assoc J        ISSN： 1911-6470            Impact factor:   1.862


× No keyword cloud information.
  66 in total

Review 1.  Extent of pelvic lymph node dissection during radical cystectomy: is bigger better?

Authors:  Debasish Sundi; Robert S Svatek; Matthew E Nielsen; Mark P Schoenberg; Trinity J Bivalacqua
Journal:  Rev Urol       Date:  2014

2.  Evaluation of current surveillance guidelines following radical cystectomy and proposal of a novel risk-based approach.

Authors:  Suzanne B Stewart-Merrill; Stephen A Boorjian; Robert Houston Thompson; Sarah P Psutka; John C Cheville; Prabin Thapa; Eric J Bergstrahl; Matthew K Tollefson; Igor Frank
Journal:  Urol Oncol       Date:  2015-05-29       Impact factor: 3.498

Review 3.  Trimodality treatment in the conservative management of infiltrating bladder cancer: a critical review of the literature.

Authors:  Orazio Caffo; Antonello Veccia; Gianni Fellin; Lucianna Russo; Salvatore Mussari; Enzo Galligioni
Journal:  Crit Rev Oncol Hematol       Date:  2012-10-22       Impact factor: 6.312

4.  Long-term outcomes of selective bladder preservation by combined-modality therapy for invasive bladder cancer: the MGH experience.

Authors:  Jason A Efstathiou; Daphna Y Spiegel; William U Shipley; Niall M Heney; Donald S Kaufman; Andrzej Niemierko; John J Coen; Rafi Y Skowronski; Jonathan J Paly; Francis J McGovern; Anthony L Zietman
Journal:  Eur Urol       Date:  2011-11-12       Impact factor: 20.096

5.  Induction chemotherapy for unresectable urothelial carcinoma of the bladder.

Authors:  Pirus Ghadjar; Fiona C Burkhard; Oliver Gautschi; George N Thalmann; Urs E Studer
Journal:  BJU Int       Date:  2010-09-14       Impact factor: 5.588

6.  Prognostic significance of lymphatic, vascular and perineural invasion for bladder cancer patients treated by radical cystectomy.

Authors:  Prasuna Muppa; Sounak Gupta; Igor Frank; Stephen A Boorjian; R Jeffrey Karnes; R Houston Thompson; Prabin Thapa; Robert F Tarrell; Loren P Herrera Hernandez; Rafael E Jimenez; John C Cheville
Journal:  Pathology       Date:  2017-03-01       Impact factor: 5.306

7.  Early and late complications of robot-assisted radical cystectomy: a standardized analysis by urinary diversion type.

Authors:  Michael Nazmy; Bertram Yuh; Mark Kawachi; Clayton S Lau; Jennifer Linehan; Nora H Ruel; Robert R Torrey; Jonathan Yamzon; Timothy G Wilson; Kevin G Chan
Journal:  J Urol       Date:  2013-10-04       Impact factor: 7.450

8.  Postoperative mortality and complications after radical cystectomy for bladder cancer in Quebec: A population-based analysis during the years 2000-2009.

Authors:  Ahmed S Zakaria; Fabiano Santos; Alice Dragomir; Simon Tanguay; Wassim Kassouf; Armen G Aprikian
Journal:  Can Urol Assoc J       Date:  2014-07       Impact factor: 1.862

9.  Radical cystectomy and extended pelvic lymphadenectomy: survival of patients with lymph node metastasis above the bifurcation of the common iliac vessels treated with surgery only.

Authors:  Kenneth Steven; Asger L Poulsen
Journal:  J Urol       Date:  2007-08-14       Impact factor: 7.450

10.  The prognostic value of histological subtype in patients with metastatic bladder cancer.

Authors:  Cheng Chen; Linkun Hu; Ye Chen; Jianquan Hou
Journal:  Oncotarget       Date:  2017-04-25
View more
  13 in total

1.  Editorial comment: understanding the cost of bladder preservation in muscle invasive bladder cancer-an evaluation of radical cystectomy versus trimodal therapy costs.

Authors:  Diana E Magee; Girish S Kulkarni
Journal:  Transl Androl Urol       Date:  2019-12

2.  Development of a radiomic signature for predicting response to neoadjuvant chemotherapy in muscle-invasive bladder cancer.

Authors:  Ambica Parmar; Abdul Aziz Qazi; Audrius Stundzia; Hao-Wen Sim; Jeremy Lewin; Ur Metser; Martin O'Malley; Aaron R Hansen
Journal:  Can Urol Assoc J       Date:  2022-03       Impact factor: 1.862

3.  Trimodal therapy vs. radical cystectomy for muscle-invasive bladder cancer: A Canadian cost-effectiveness analysis.

Authors:  Ronald Kool; Ivan Yanev; Tarek Hijal; Marie Vanhuyse; Fabio L Cury; Luis Souhami; Wassim Kassouf; Alice Dragomir
Journal:  Can Urol Assoc J       Date:  2022-06       Impact factor: 2.052

4.  Histology at transurethral resection of bladder tumor and radical cystectomy for bladder cancer: Insights from population-based data.

Authors:  Tina Dyer; D Robert Siemens; Pria Nippak; Julien Meyer; Christopher M Booth
Journal:  Can Urol Assoc J       Date:  2021-04       Impact factor: 1.862

5.  The use of perioperative chemotherapy in patients undergoing radical cystectomy for bladder cancer in Quebec, Canada, 2000-2016.

Authors:  Michel D Wissing; Wassim Kassouf; Simon Tanguay; Armen G Aprikian
Journal:  Can Urol Assoc J       Date:  2019-11-29       Impact factor: 1.862

6.  Radical cystectomy for clinical T4b urothelial carcinoma: An Ontario, single-center experience.

Authors:  Daniel Tesolin; Asmaa Ismail; Hazem Elmansy; Walid Shahrour; Owen Prowse; Ahmed Kotb
Journal:  Can Urol Assoc J       Date:  2022-05       Impact factor: 2.052

7.  Identification of Key Biomarkers in Bladder Cancer: Evidence from a Bioinformatics Analysis.

Authors:  Chuan Zhang; Mandy Berndt-Paetz; Jochen Neuhaus
Journal:  Diagnostics (Basel)       Date:  2020-01-24

Review 8.  Bladder-sparing protocols in the treatment of muscle-invasive bladder cancer.

Authors:  Côme Tholomier; Luis Souhami; Wassim Kassouf
Journal:  Transl Androl Urol       Date:  2020-12

9.  A TP53-Associated Immune Prognostic Signature for the Prediction of Overall Survival and Therapeutic Responses in Muscle-Invasive Bladder Cancer.

Authors:  Xiangkun Wu; Daojun Lv; Chao Cai; Zhijian Zhao; Ming Wang; Wenzhe Chen; Yongda Liu
Journal:  Front Immunol       Date:  2020-12-17       Impact factor: 7.561

10.  Cases - Clear-cell urothelial carcinoma of the bladder.

Authors:  Carolyn MacLeod; Ernest P Chan; Kamilia Rizkalla; Alp Sener; Jeffrey Campbell
Journal:  Can Urol Assoc J       Date:  2021-12       Impact factor: 1.862
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.